1 – 10 of 12
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Disease activity trajectories in rheumatoid arthritis : a tool for prediction of outcome
(
- Contribution to journal › Article
- 2017
-
Mark
The association between anti-carbamylated protein (anti-CarP) antibodies and radiographic progression in early rheumatoid arthritis : A study exploring replication and the added value to ACPA and rheumatoid factor
(
- Contribution to journal › Article
-
Mark
Rheumatoid arthritis phenotype at presentation differs depending on the number of autoantibodies present
(
- Contribution to journal › Article
- 2016
-
Mark
Persistently active disease is common in patients with rheumatoid arthritis, particularly in women : a long-term inception cohort study
(
- Contribution to journal › Article
-
Mark
Anticitrullinated protein antibodies and rheumatoid factor are associated with increased mortality but with different causes of death in patients with rheumatoid arthritis: a longitudinal study in three European cohorts.
2016) In Annals of the Rheumatic Diseases(
- Contribution to journal › Article
- 2010
-
Mark
Influence of gender on assessments of disease activity and function in early rheumatoid arthritis in relation to radiographic joint damage
(
- Contribution to journal › Article
- 2009
-
Mark
Hand bone loss measured by digital X-ray radiogrammetry is a predictor of joint damage in early rheumatoid arthritis
(
- Contribution to journal › Article
- 2007
-
Mark
Sex: a major predictor of remission in early rheumatoid arthritis?
(
- Contribution to journal › Article
-
Mark
EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases
(
- Contribution to journal › Article
- 2005
-
Mark
Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate - A two-year randomized trial
(
- Contribution to journal › Article